Fundraising Fox

Cyrano Therateutics

Delray Beach, US · 3 known investors

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

RG
Rick GeoffrionFounder, President and CEO & Board Member

Investors · 3

Remiges Ventures, Inc.✓ verifiedSeattle
DeepWork Capital✓ verifiedOrlando
Lumira Ventures✓ verifiedToronto · $1M – $10M

Competitors · 1

by search overlap
Osmosis11 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies competing with Cyrano Therateutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cyrano Therateutics do?
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
Who founded Cyrano Therateutics?
Cyrano Therateutics was founded by Rick Geoffrion.
Who are Cyrano Therateutics's investors?
Cyrano Therateutics's investors include Remiges Ventures, Inc., DeepWork Capital, Lumira Ventures.
Where is Cyrano Therateutics headquartered?
Cyrano Therateutics is headquartered in Delray Beach, US.